Publications

2026

• Teaching NeuroImages: Clinical Utility of 7T MRI in the Management of a Basilar Artery Perforator Aneurysm. Agripnidis, T., Kerleroux, B., Hak, J. F., Stellmann, J. P. & Testud, B. (2026). Neurology, 106: e214874. doi:10.1212/WNL.0000000000214874
• Tantalum sedimentation in Onyx® syringes: An in-vitro study of agitation strategies to maintain fluoroscopic visibility. Agripnidis, T., Tradi, F., Holay, Q., … Stellmann, J. P., … et al. (2026). J Neuroradiol, 53: 101408. doi:10.1016/j.neurad.2025.101408
• From "watch-and-wait" to "watch-and-measure": The emerging role of metabolic MRI in distinguishing radiation necrosis from tumor progression in brain metastases. Benzakoun, J. & Stellmann, J. P. (2026). Diagn Interv Imaging, 107: 205-206. doi:10.1016/j.diii.2026.02.005
• Probable disseminated cryptococcosis relapse in a patient with Hodgkin’s lymphoma treated with induction therapy resumption and autologous stem cell transplant. Bes-Berlandier, H., Stellmann, J. P., Berro, S., Choufi, B., Sohn, C. et al. (2026). J Mycol Med, 36: 101603. doi:10.1016/j.mycmed.2026.101603
• Real-life walking speed: A new marker of progression in a primary progressive multiple sclerosis cohort study?. Cotinat, M., Heesen, C., Boudiaf, I., … Ranjeva, J. P. & Stellmann, J. P. (2026). Mult Scler: 13524585261476543. doi:10.1177/13524585261476543
• OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD. Pakeerathan, T., Davis, J., Henderson, A. D., … Stellmann, J. P., … et al. (2026). Neurol Neuroimmunol Neuroinflamm, 13: e200531. doi:10.1212/NXI.0000000000200531
• Twelve-week intermittent hypoxia intervention in multiple sclerosis – A safety and feasibility trial. Schubert, C., Suling, A., Ramien, C., … Stellmann, J. P., … et al. (2026). Mult Scler Relat Disord, 110: 107176. doi:10.1016/j.msard.2026.107176
• Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disorders. Tkachenko, D., Ayzenberg, I., Schöppe, L. M., … Stellmann, J. P., … et al. (2026). Neurol Res Pract, 8. doi:10.1186/s42466-026-00486-4
• The presynaptic protein bassoon is a biofluid biomarker of synaptic pathology in multiple sclerosis. Woo, M. S., Rothammer, N., Bal, L. C., … Stellmann, J. P., … et al. (2026). EBioMedicine, 128: 106282. doi:10.1016/j.ebiom.2026.106282

2025

• Diagnostic Utility of Kappa Free Light Chain Index in Adults With Inaugural Optic Neuritis. Demortiere, S., Stolowy, N., Perriguey, M., … Stellmann, J. P., … et al. (2025). Neurol Neuroimmunol Neuroinflamm, 12: e200386. doi:10.1212/NXI.0000000000200386
• Fluorescein Angiography as a Surrogate Marker of Disease Activity in Susac Syndrome. Guttieres, L., Vannelli, L., Demortiere, S., … Stellmann, J. P., … et al. (2025). Neurol Neuroimmunol Neuroinflamm, 12: e200379. doi:10.1212/NXI.0000000000200379
• Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD. Häußler, V., Trebst, C., Engels, D., … Berthele, A. & Stellmann, J. P. (2025). J Neurol Neurosurg Psychiatry, 96: 582-592. doi:10.1136/jnnp-2024-334764
• Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study). Kretschmer, J. R., Tkachenko, D., Kümpfel, T., … Stellmann, J. P., … et al. (2025). Front Immunol, 16: 1575613. doi:10.3389/fimmu.2025.1575613
• Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study). Passoke, S., Stern, C., Häußler, V., … Stellmann, J. P., … et al. (2025). J Neurol Neurosurg Psychiatry, 96: 296-305. doi:10.1136/jnnp-2024-333994
• Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis. Rigollet, C., Freeman, S. A., Perriguey, M., Stellmann, J. P., Graille-Avy, L. et al. (2025). Neurotherapeutics, 22: e00554. doi:10.1016/j.neurot.2025.e00554
• Early structural hub disruption leads to premature functional adaption in multiple sclerosis. Stellmann, J. P., Maarouf, A., Nicolescu, M., Boutiere, C., Rico, A. et al. (2025). Brain Struct Funct, 230: 172. doi:10.1007/s00429-025-03023-2
• OCT-Based Retina Assessment Reflects Visual Impairment in Multiple Sclerosis. Stolowy, N., Gutmann, L., Lüpke, M., … Zimmermann, H. G. & Stellmann, J. P. (2025). Invest Ophthalmol Vis Sci, 66: 39. doi:10.1167/iovs.66.2.39

2024

• Benefits of aHSCT over alemtuzumab in patients with multiple sclerosis besides disability and relapses: Sustained improvement in cognition and quality of life. Braun, B., Fischbach, F., Richter, J., … Stellmann, J. P., … et al. (2024). Mult Scler Relat Disord, 82: 105414. doi:10.1016/j.msard.2023.105414
• Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD. Duchow, A., Bellmann-Strobl, J., Friede, T., … Stellmann, J. P. & Häußler, V. (2024). Ann Neurol, 95: 720-732. doi:10.1002/ana.26858
• Cortical Lesions as an Early Hallmark of Multiple Sclerosis: Visualization by 7 T MRI. Durozard, P., Maarouf, A., Zaaraoui, W., Stellmann, J. P., Boutière, C. et al. (2024). Invest Radiol, 59: 747-753. doi:10.1097/RLI.0000000000001082
• Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis. Krämer, J., Balloff, C., Weise, M., … Stellmann, J. P., … et al. (2024). Nat Commun, 15: 5243. doi:10.1038/s41467-024-49309-7
• Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management. Kümpfel, T., Giglhuber, K., Aktas, O., … Stellmann, J. P., … et al. (2024). J Neurol, 271: 141-176. doi:10.1007/s00415-023-11910-z
• Active and non-active progression independent of relapse activity within the first 20 years of relapsing multiple sclerosis. Maarouf, A., Stellmann, J. P., Rico, A., Boutiere, C., Demortiere, S. et al. (2024). J Neurol Neurosurg Psychiatry, 95: 974-978. doi:10.1136/jnnp-2024-333597
• Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision. Nicolescu, M., Häußler, V., Paul, F., … Stolowy, N. & Stellmann, J. P. (2024). J Neurol, 272: 86. doi:10.1007/s00415-024-12803-5
• Rapid differentiation of MOGAD and MS after a single optic neuritis. Pakeerathan, T., Havla, J., Schwake, C., … Stellmann, J. P., … et al. (2024). J Neurol, 271: 7222-7231. doi:10.1007/s00415-024-12666-w
• Neurofilament Light Chain Levels Interact with Neurodegenerative Patterns and Motor Neuron Dysfunction in Amyotrophic Lateral Sclerosis. Tilsley, P., Moutiez, A., Brodovitch, A., … Grapperon, A. M. & Stellmann, J. P. (2024). AJNR Am J Neuroradiol, 45: 494-503. doi:10.3174/ajnr.A8154

2023

• Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline. Bayas, A., Berthele, A., Blank, N., … Stellmann, J. P., … et al. (2023). Ther Adv Neurol Disord, 16: 17562864231180730. doi:10.1177/17562864231180730
• Translation and validation of the multiple sclerosis walking scale 12 for the German population – the MSWS-12/D. Chorschew, A., Kesgin, F., Bellmann-Strobl, J., … Stellmann, J. P. & Schmitz-Hübsch, T. (2023). Health Qual Life Outcomes, 21: 110. doi:10.1186/s12955-023-02190-2
• Topological reorganization of brain network might contribute to the resilience of cognitive functioning in mildly disabled relapsing remitting multiple sclerosis. Has Silemek, A. C., Nolte, G., Pöttgen, J., … Gold, S. M. & Stellmann, J. P. (2023). J Neurosci Res, 101: 143-161. doi:10.1002/jnr.25135
• Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-Study. Hümmert, M. W., Bütow, F., Tkachenko, D., … Stellmann, J. P., … et al. (2023). Neurol Neuroimmunol Neuroinflamm, 10. doi:10.1212/NXI.0000000000200082
• Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study). Hümmert, M. W., Stern, C., Paul, F., … Stellmann, J. P., … et al. (2023). Mult Scler, 29: 819-831. doi:10.1177/13524585231151212
• Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis. Jarius, S., Aktas, O., Ayzenberg, I., … Stellmann, J. P., … et al. (2023). J Neurol, 270: 3341-3368. doi:10.1007/s00415-023-11634-0
• Visual function resists early neurodegeneration in the visual system in primary progressive multiple sclerosis. Rosenkranz, S. C., Gutmann, L., Has Silemek, A. C., … Zimmermann, H. & Stellmann, J. P. (2023). J Neurol Neurosurg Psychiatry, 94: 924-933. doi:10.1136/jnnp-2023-331183
• The MoxFo initiative-Mechanisms of action: Biomarkers in multiple sclerosis exercise studies. Rosenkranz, S. C., Ploughman, M., Hvid, L. G., … Stellmann, J. P., … et al. (2023). Mult Scler, 29: 1569-1577. doi:10.1177/13524585231204453
• Contribution of the MP2RAGE 7T Sequence in MS Lesions of the Cervical Spinal Cord. Testud, B., Fabiani, N., Demortière, S., … Stellmann, J. P. & Callot, V. (2023). AJNR Am J Neuroradiol, 44: 1101-1107. doi:10.3174/ajnr.A7964
• White Matter Spreading MRI Pattern of Listeria monocytogenes. Testud, B., Manchon, A., Stellmann, J. P. & Hak, J. F. (2023). Neurology, 101: 972-973. doi:10.1212/WNL.0000000000207803
• Effect of geometric distortion correction on thickness and volume measurements of cortical parcellations in 3D T1w gradient echo sequences. Thaler, C., Sedlacik, J., Forkert, N. D., Stellmann, J. P., Schön, G. et al. (2023). PLoS One, 18: e0284440. doi:10.1371/journal.pone.0284440
• Distal cerebral vasospasm treatment following aneurysmal subarachnoid hemorrhage using the Comaneci device: technical feasibility and single-center preliminary results. Thiery, L., Carle, X., Testud, B., … Stellmann, J. P., … et al. (2023). J Neurointerv Surg, 15: 325-329. doi:10.1136/neurintsurg-2022-018699
• Physical fitness moderates the association between brain network impairment and both motor function and cognition in progressive multiple sclerosis. Tilsley, P., Strohmeyer, I. A., Heinrich, I., … Gold, S. M. & Stellmann, J. P. (2023). J Neurol, 270: 4876-4888. doi:10.1007/s00415-023-11806-y

2022

• Borrowing strength from adults: Transferability of AI algorithms for paediatric brain and tumour segmentation. Drai, M., Testud, B., Brun, G., … Girard, N. & Stellmann, J. P. (2022). Eur J Radiol, 151: 110291. doi:10.1016/j.ejrad.2022.110291
• Alterations of Microstructure and Sodium Homeostasis in Fast Amyotrophic Lateral Sclerosis Progressors: A Brain DTI and Sodium MRI Study. El Mendili, M. M., Grapperon, A. M., Dintrich, R., Stellmann, J. P., Ranjeva, J. P. et al. (2022). AJNR Am J Neuroradiol, 43: 984-990. doi:10.3174/ajnr.A7559
• The Sylvia Lawry Centre for Multiple Sclerosis Research (SLCMSR)–Critical review facing the 20 anniversary. Heesen, C., Magyari, M., Stellmann, J. P., Lederer, C., Giovannoni, G. et al. (2022). Mult Scler Relat Disord, 63: 103885. doi:10.1016/j.msard.2022.103885
• Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Disease: CHANCE NMO Study. Hümmert, M. W., Schöppe, L. M., Bellmann-Strobl, J., … Stellmann, J. P., … et al. (2022). Neurology, 98: e1184-e1196. doi:10.1212/WNL.0000000000200052
• Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab. Perriguey, M., Maarouf, A., Stellmann, J. P., Rico, A., Boutiere, C. et al. (2022). Neurol Neuroimmunol Neuroinflamm, 9. doi:10.1212/NXI.0000000000001115
• Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders. Ringelstein, M., Ayzenberg, I., Lindenblatt, G., … Stellmann, J. P., … et al. (2022). Neurol Neuroimmunol Neuroinflamm, 9. doi:10.1212/NXI.0000000000001100
• Brain grey matter perfusion in primary progressive multiple sclerosis: Mild decrease over years and regional associations with cognition and hand function. Testud, B., Delacour, C., El Ahmadi, A. A., … Has Silemek, A. C. & Stellmann, J. P. (2022). Eur J Neurol, 29: 1741-1752. doi:10.1111/ene.15289
• Tumoral Hemorrhagic Stroke Revealing Carotid Angiosarcoma-Related Cerebral Metastases. Testud, B., Stellmann, J. P., Girard, N. & Hak, J. F. (2022). Neurol India, 70: 2246-2248. doi:10.4103/0028-3886.359227

2021

• Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody-Associated Diseases. Avouac, A., Maarouf, A., Stellmann, J. P., Rico, A., Boutiere, C. et al. (2021). Neurol Neuroimmunol Neuroinflamm, 8. doi:10.1212/NXI.0000000000000977
• Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive Patients. Ayzenberg, I., Richter, D., Henke, E., … Stellmann, J. P., … et al. (2021). Neurol Neuroimmunol Neuroinflamm, 8. doi:10.1212/NXI.0000000000000985
• A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica. Giovannelli, J., Ciron, J., Cohen, M., … Stellmann, J. P., … et al. (2021). Ann Clin Transl Neurol, 8: 2025-2037. doi:10.1002/acn3.51451
• Delayed access to conscious processing in multiple sclerosis: Reduced cortical activation and impaired structural connectivity. Has Silemek, A. C., Ranjeva, J. P., Audoin, B., … Weygandt, M. & Stellmann, J. P. (2021). Hum Brain Mapp, 42: 3379-3395. doi:10.1002/hbm.25440
• aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis. Häußler, V., Ufer, F., Pöttgen, J., … Heesen, C. & Stellmann, J. P. (2021). Ann Clin Transl Neurol, 8: 1269-1278. doi:10.1002/acn3.51366
• Arm Ergometry to Improve Mobility in Progressive Multiple Sclerosis (AMBOS)-Results of a Pilot Randomized Controlled Trial. Heinrich, I., Rosenthal, F., Patra, S., … Stellmann, J. P., … et al. (2021). Front Neurol, 12: 644533. doi:10.3389/fneur.2021.644533
• Study protocol for a randomised controlled trial of a web-based behavioural lifestyle programme for emPOWERment in early Multiple Sclerosis (POWER@MS1). Krause, N., Riemann-Lorenz, K., Steffen, T., … Stellmann, J. P., … et al. (2021). BMJ Open, 11: e041720. doi:10.1136/bmjopen-2020-041720
• Validation of Computer-Adaptive Contrast Sensitivity as a Tool to Assess Visual Impairment in Multiple Sclerosis Patients. Rosenkranz, S. C., Kaulen, B., Zimmermann, H. G., … Dorr, M. & Stellmann, J. P. (2021). Front Neurosci, 15: 591302. doi:10.3389/fnins.2021.591302
• Cognitive performance shows domain specific associations with regional cortical thickness in multiple sclerosis. Stellmann, J. P., Wanke, N., Maarouf, A., Gellißen, S., Heesen, C. et al. (2021). Neuroimage Clin, 30: 102606. doi:10.1016/j.nicl.2021.102606
• Distinctive MRI features of paraneoplastic encephalitis with anti-Ri antibodies. Testud, B., Brun, G., Kaphan, E., Stellmann, J. P., Girard, N. et al. (2021). Rev Neurol (Paris), 177: 315-317. doi:10.1016/j.neurol.2020.05.009
• Perfusion-weighted techniques in MRI grading of pediatric cerebral tumors: efficiency of dynamic susceptibility contrast and arterial spin labeling. Testud, B., Brun, G., Varoquaux, A., … Girard, N. & Stellmann, J. P. (2021). Neuroradiology, 63: 1353-1366. doi:10.1007/s00234-021-02640-y
• T1 Relaxation Times in the Cortex and Thalamus Are Associated With Working Memory and Information Processing Speed in Patients With Multiple Sclerosis. Thaler, C., Hartramph, I., Stellmann, J. P., Heesen, C., Bester, M. et al. (2021). Front Neurol, 12: 789812. doi:10.3389/fneur.2021.789812
• Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging. Thaler, C., Kyselyova, A. A., Faizy, T. D., … Stellmann, J. P., … et al. (2021). PLoS One, 16: e0245844. doi:10.1371/journal.pone.0245844

2020

• COVID-19-White matter and globus pallidum lesions: Demyelination or small-vessel vasculitis?. Brun, G., Hak, J. F., Coze, S., … Girard, N. & Stellmann, J. P. (2020). Neurol Neuroimmunol Neuroinflamm, 7. doi:10.1212/NXI.0000000000000777
• Moving exercise research in multiple sclerosis forward (the MoXFo initiative): Developing consensus statements for research. Dalgas, U., Hvid, L. G., Kwakkel, G., … Stellmann, J. P., … et al. (2020). Mult Scler, 26: 1303-1308. doi:10.1177/1352458520910360
• The Myelin Water Fraction Serves as a Marker for Age-Related Myelin Alterations in the Cerebral White Matter – A Multiparametric MRI Aging Study. Faizy, T. D., Thaler, C., Broocks, G., … Stellmann, J. P., … et al. (2020). Front Neurosci, 14: 136. doi:10.3389/fnins.2020.00136
• Distinct Functional Connectivity Signatures of Impaired Social Cognition in Multiple Sclerosis. Golde, S., Heine, J., Pöttgen, J., … Stellmann, J. P., … et al. (2020). Front Neurol, 11: 507. doi:10.3389/fneur.2020.00507
• Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability. Has Silemek, A. C., Fischer, L., Pöttgen, J., … Gold, S. M. & Stellmann, J. P. (2020). Neuroimage Clin, 25: 102177. doi:10.1016/j.nicl.2020.102177
• Blunted neural and psychological stress processing predicts future grey matter atrophy in multiple sclerosis. Meyer-Arndt, L., Hetzer, S., Asseyer, S., … Stellmann, J. P., … et al. (2020). Neurobiol Stress, 13: 100244. doi:10.1016/j.ynstr.2020.100244
• Feasibility of a smartphone app to enhance physical activity in progressive MS: a pilot randomized controlled pilot trial over three months. Nasseri, N. N., Ghezelbash, E., Zhai, Y., … Rahn, A. C. & Stellmann, J. P. (2020). PeerJ, 8: e9303. doi:10.7717/peerj.9303
• Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders. Ringelstein, M., Harmel, J., Zimmermann, H., … Stellmann, J. P., … et al. (2020). Neurology, 94: e407-e418. doi:10.1212/WNL.0000000000008684
• Assessing the effect of an evidence-based patient online educational tool for people with multiple sclerosis called UMIMS-understanding magnetic resonance imaging in multiple sclerosis: study protocol for a double-blind, randomized controlled trial. Schiffmann, I., Freund, M., Vettorazzi, E., Stellmann, J. P., Heyer-Borchelt, S. et al. (2020). Trials, 21: 1008. doi:10.1186/s13063-020-04855-5
• Aerobic Exercise Induces Functional and Structural Reorganization of CNS Networks in Multiple Sclerosis: A Randomized Controlled Trial. Stellmann, J. P., Maarouf, A., Schulz, K. H., Baquet, L., Pöttgen, J. et al. (2020). Front Hum Neurosci, 14: 255. doi:10.3389/fnhum.2020.00255
• Smartphone Accelerometry: A Smart and Reliable Measurement of Real-Life Physical Activity in Multiple Sclerosis and Healthy Individuals. Zhai, Y., Nasseri, N., Pöttgen, J., … Heesen, C. & Stellmann, J. P. (2020). Front Neurol, 11: 688. doi:10.3389/fneur.2020.00688

2019

• Emotions towards magnetic resonance imaging in people with multiple sclerosis. Engels, K., Schiffmann, I., Weierstall, R., … Stellmann, J. P. & Heesen, C. (2019). Acta Neurol Scand, 139: 497-504. doi:10.1111/ane.13082
• Spectrally fat-suppressed coronal 2D TSE sequences may be more sensitive than 2D STIR for the detection of hyperintense optic nerve lesions. Faizy, T. D., Broocks, G., Frischmuth, I., … Stellmann, J. P., … et al. (2019). Eur Radiol, 29: 6266-6274. doi:10.1007/s00330-019-06255-z
• Development of Cortical Lesion Volumes on Double Inversion Recovery MRI in Patients With Relapse-Onset Multiple Sclerosis. Faizy, T. D., Broocks, G., Thaler, C., … Stellmann, J. P., … et al. (2019). Front Neurol, 10: 133. doi:10.3389/fneur.2019.00133
• Magnetic resonance imaging as a prognostic disability marker in clinically isolated syndrome: A systematic review. Rahn, A. C., Köpke, S., Stellmann, J. P., Schiffmann, I., Lukas, C. et al. (2019). Acta Neurol Scand, 139: 18-32. doi:10.1111/ane.13010
• Impairment and restrictions in possibly benign multiple sclerosis. Schaefer, L. M., Poettgen, J., Fischer, A., Gold, S., Stellmann, J. P. et al. (2019). Brain Behav, 9: e01259. doi:10.1002/brb3.1259
• Relapse rates and long-term outcome in primary angiitis of the central nervous system. Schuster, S., Ozga, A. K., Stellmann, J. P., Deb-Chatterji, M., Häußler, V. et al. (2019). J Neurol, 266: 1481-1489. doi:10.1007/s00415-019-09285-1
• Is multiple sclerosis progression associated with the HLA-DR15 haplotype?. Stürner, K. H., Siembab, I., Schön, G., Stellmann, J. P., Heidari, N. et al. (2019). Mult Scler J Exp Transl Clin, 5: 2055217319894615. doi:10.1177/2055217319894615

2018

• Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis-a randomized controlled trial. Baquet, L., Hasselmann, H., Patra, S., Stellmann, J. P., Vettorazzi, E. et al. (2018). PeerJ, 6: e6037. doi:10.7717/peerj.6037
• Age-Related Measurements of the Myelin Water Fraction derived from 3D multi-echo GRASE reflect Myelin Content of the Cerebral White Matter. Faizy, T. D., Kumar, D., Broocks, G., … Stellmann, J. P., … et al. (2018). Sci Rep, 8: 14991. doi:10.1038/s41598-018-33112-8
• Perceptions on the value of bodily functions in multiple sclerosis. Heesen, C., Haase, R., Melzig, S., … Ziemssen, T. & Stellmann, J. P. (2018). Acta Neurol Scand, 137: 356-362. doi:10.1111/ane.12881
• MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature. Jarius, S., Ruprecht, K., Stellmann, J. P., Huss, A., Ayzenberg, I. et al. (2018). J Neuroinflammation, 15: 88. doi:10.1186/s12974-018-1108-6
• Can resistance training impact MRI outcomes in relapsing-remitting multiple sclerosis?. Kjølhede, T., Siemonsen, S., Wenzel, D., Stellmann, J. P., Ringgaard, S. et al. (2018). Mult Scler, 24: 1356-1365. doi:10.1177/1352458517722645
• Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions. Kleiter, I., Gahlen, A., Borisow, N., … Stellmann, J. P., … et al. (2018). Neurol Neuroimmunol Neuroinflamm, 5: e504. doi:10.1212/NXI.0000000000000504
• Distribution of brain sodium long and short relaxation times and concentrations: a multi-echo ultra-high field 23Na MRI study. Ridley, B., Nagel, A. M., Bydder, M., Maarouf, A., Stellmann, J. P. et al. (2018). Sci Rep, 8: 4357. doi:10.1038/s41598-018-22711-0
• Low clinical conversion rate in clinically isolated syndrome patients – diagnostic benefit of McDonald 2010 criteria?. Rosenkranz, S. C., Kaulen, B., Neuhaus, A., … Stellmann, J. P. & Heesen, C. (2018). Eur J Neurol, 25: 247-e9. doi:10.1111/ene.13476
• Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring. Stoessel, D., Stellmann, J. P., Willing, A., Behrens, B., Rosenkranz, S. C. et al. (2018). Front Hum Neurosci, 12: 226. doi:10.3389/fnhum.2018.00226
• A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial). Stürner, K. H., Stellmann, J. P., Dörr, J., Paul, F., Friede, T. et al. (2018). J Neurol Neurosurg Psychiatry, 89: 330-338. doi:10.1136/jnnp-2017-317101
• The use of multiparametric quantitative magnetic resonance imaging for evaluating visually assigned lesion groups in patients with multiple sclerosis. Thaler, C., Faizy, T. D., Sedlacik, J., Bester, M., Stellmann, J. P. et al. (2018). J Neurol, 265: 127-133. doi:10.1007/s00415-017-8683-9

2017

• Influence of female sex and fertile age on neuromyelitis optica spectrum disorders. Borisow, N., Kleiter, I., Gahlen, A., … Stellmann, J. P., … et al. (2017). Mult Scler, 23: 1092-1103. doi:10.1177/1352458516671203
• Reliability of cortical lesion detection on double inversion recovery MRI applying the MAGNIMS-Criteria in multiple sclerosis patients within a 16-months period. Faizy, T. D., Thaler, C., Ceyrowski, T., … Stellmann, J. P., … et al. (2017). PLoS One, 12: e0172923. doi:10.1371/journal.pone.0172923
• Ruxolitinib treatment in a patient with neuromyelitis optica: A case report. Hodecker, S. C., Stellmann, J. P., Rosenkranz, S. C., Young, K., Holst, B. et al. (2017). Neurol Neuroimmunol Neuroinflamm, 4: e328. doi:10.1212/NXI.0000000000000328
• Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing-remitting MS. Stellmann, J. P., Cetin, H., Young, K. L., Hodecker, S., Pöttgen, J. et al. (2017). Brain Behav, 7: e00614. doi:10.1002/brb3.614
• Reduced rich-club connectivity is related to disability in primary progressive MS. Stellmann, J. P., Hodecker, S., Cheng, B., Wanke, N., Young, K. L. et al. (2017). Neurol Neuroimmunol Neuroinflamm, 4: e375. doi:10.1212/NXI.0000000000000375
• Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response. Stellmann, J. P., Krumbholz, M., Friede, T., Gahlen, A., Borisow, N. et al. (2017). J Neurol Neurosurg Psychiatry, 88: 639-647. doi:10.1136/jnnp-2017-315603
• No relevant impact of ambient temperature on disability measurements in a large cohort of patients with multiple sclerosis. Stellmann, J. P., Young, K. L., Vettorazzi, E., Pöttgen, J. & Heesen, C. (2017). Eur J Neurol, 24: 851-857. doi:10.1111/ene.13301
• T1 Recovery Is Predominantly Found in Black Holes and Is Associated with Clinical Improvement in Patients with Multiple Sclerosis. Thaler, C., Faizy, T. D., Sedlacik, J., … Stellmann, J. P., … et al. (2017). AJNR Am J Neuroradiol, 38: 264-269. doi:10.3174/ajnr.A5004
• T1w dark blood imaging improves detection of contrast enhancing lesions in multiple sclerosis. Thaler, C., Schneider, T., Sedlacik, J., Kutzner, D., Stellmann, J. P. et al. (2017). PLoS One, 12: e0183099. doi:10.1371/journal.pone.0183099

2016

• Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. Andlauer, T. F., Buck, D., Antony, G., … Stellmann, J. P., … et al. (2016). Sci Adv, 2: e1501678. doi:10.1126/sciadv.1501678
• Heterogeneity of Multiple Sclerosis Lesions in Multislice Myelin Water Imaging. Faizy, T. D., Thaler, C., Kumar, D., … Stellmann, J. P., … et al. (2016). PLoS One, 11: e0151496. doi:10.1371/journal.pone.0151496
• Improved Lesion Detection by Using Axial T2-Weighted MRI with Full Spinal Cord Coverage in Multiple Sclerosis. Galler, S., Stellmann, J. P., Young, K. L., Kutzner, D., Heesen, C. et al. (2016). AJNR Am J Neuroradiol, 37: 963-9. doi:10.3174/ajnr.A4638
• Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses. Kleiter, I., Gahlen, A., Borisow, N., … Stellmann, J. P., … et al. (2016). Ann Neurol, 79: 206-16. doi:10.1002/ana.24554
• Chronic T2 Lesions in Multiple Sclerosis are Heterogeneous Regarding Phase MR Imaging. Siemonsen, S., Young, K. L., Bester, M., … Fiehler, J. & Stellmann, J. P. (2016). Clin Neuroradiol, 26: 457-464. doi:10.1007/s00062-015-0389-8
• Fampridine and real-life walking in multiple sclerosis: Low predictive value of clinical test for habitual short-term changes. Stellmann, J. P., Jlussi, M., Neuhaus, A., Lederer, C., Daumer, M. et al. (2016). J Neurol Sci, 368: 318-25. doi:10.1016/j.jns.2016.07.051
• Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting. von Gumberz, J., Mahmoudi, M., Young, K., … Siemonsen, S. & Stellmann, J. P. (2016). PeerJ, 4: e2442. doi:10.7717/peerj.2442
• "History had taken such a large piece out of my life" – Neuroscientist refugees from Hamburg during National Socialism. Zeidman, L. A., von Villiez, A., Stellmann, J. P. & van den Bussche, H. (2016). J Hist Neurosci, 25: 275-98. doi:10.1080/0964704X.2015.1121696

2015

• Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients. Bester, M., Forkert, N. D., Stellmann, J. P., Stürner, K., Aly, L. et al. (2015). PLoS One, 10: e0119356. doi:10.1371/journal.pone.0119356
• Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array. Dankowski, T., Buck, D., Andlauer, T. F., … Stellmann, J. P., … et al. (2015). Genet Epidemiol, 39: 601-8. doi:10.1002/gepi.21933
• Ecological validity of walking capacity tests in multiple sclerosis. Stellmann, J. P., Neuhaus, A., Götze, N., Briken, S., Lederer, C. et al. (2015). PLoS One, 10: e0123822. doi:10.1371/journal.pone.0123822
• [Stem cell transplantation for multiple sclerosis. Hamburg experiences and state of international research]. Stellmann, J. P., Stürner, K. H., Ufer, F., Havemeister, S., Pöttgen, J. et al. (2015). Nervenarzt, 86: 989-96. doi:10.1007/s00115-015-4305-x
• Regression to the mean and predictors of MRI disease activity in RRMS placebo cohorts–is there a place for baseline-to-treatment studies in MS?. Stellmann, J. P., Stürner, K. H., Young, K. L., Siemonsen, S., Friede, T. et al. (2015). PLoS One, 10: e0116559. doi:10.1371/journal.pone.0116559
• Introducing a new method to assess vision: Computer-adaptive contrast-sensitivity testing predicts visual functioning better than charts in multiple sclerosis patients. Stellmann, J. P., Young, K. L., Pöttgen, J., Dorr, M. & Heesen, C. (2015). Mult Scler J Exp Transl Clin, 1: 2055217315596184. doi:10.1177/2055217315596184
• T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients. Thaler, C., Faizy, T., Sedlacik, J., Holst, B., Stellmann, J. P. et al. (2015). PLoS One, 10: e0144693. doi:10.1371/journal.pone.0144693

2014

• Magnetic resonance imaging in multiple sclerosis–patients’ experiences, information interests and responses to an education programme. Brand, J., Köpke, S., Kasper, J., … Stellmann, J. P., … et al. (2014). PLoS One, 9: e113252. doi:10.1371/journal.pone.0113252
• Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1. Sospedra, M., Schippling, S., Yousef, S., … Stellmann, J. P., … et al. (2014). Clin Infect Dis, 59: 1588-92. doi:10.1093/cid/ciu682
• Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a systematic literature review. Stellmann, J. P., Neuhaus, A., Lederer, C., Daumer, M. & Heesen, C. (2014). PLoS One, 9: e92761. doi:10.1371/journal.pone.0092761
• A 3meter Timed Tandem Walk is an early marker of motor and cerebellar impairment in fully ambulatory MS patients. Stellmann, J. P., Vettorazzi, E., Poettgen, J. & Heesen, C. (2014). J Neurol Sci, 346: 99-106. doi:10.1016/j.jns.2014.08.001

2013

• A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis. Galea, I., Lederer, C., Neuhaus, A., … Stellmann, P., … et al. (2013). Eur J Neurol, 20: 1107-9. doi:10.1111/ene.12016
• Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool. Heesen, C., Gaissmaier, W., Nguyen, F., Stellmann, J. P., Kasper, J. et al. (2013). PLoS One, 8: e59042. doi:10.1371/journal.pone.0059042
• Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patients. Hofmann, A., Stellmann, J. P., Kasper, J., Ufer, F., Elias, W. G. et al. (2013). Mult Scler, 19: 920-5. doi:10.1177/1352458512461967
• Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Lutterotti, A., Yousef, S., Sputtek, A., Stürner, K. H., Stellmann, J. P. et al. (2013). Sci Transl Med, 5: 188ra75. doi:10.1126/scitranslmed.3006168
• Comparison of patient-reported outcome measures in multiple sclerosis. Schäffler, N., Schönberg, P., Stephan, J., Stellmann, J. P., Gold, S. M. et al. (2013). Acta Neurol Scand, 128: 114-21. doi:10.1111/ane.12083

2012

• Placebo cohorts in phase-3 MS treatment trials – predictors for on-trial disease activity 1990-2010 based on a meta-analysis and individual case data. Stellmann, J. P., Neuhaus, A., Herich, L., Schippling, S., Roeckel, M. et al. (2012). PLoS One, 7: e50347. doi:10.1371/journal.pone.0050347

2007

• [Chronic facial pain due to a brainstem cavernoma]. Stellmann, J. P., Kuhn, M. & Töpper, R. (2007). Fortschr Neurol Psychiatr, 75: 552-4. doi:10.1055/s-2007-980088